(1)
Al-Dughaishi, M.; Shalaby, A.; Al-Ribkhi, K.; Boudaka, A.; Boulassel, M.-R.; Saleh, J. The Value of Programmed Death Ligand 1 Expression in Cancer Patients Treated With Neoadjuvant Chemotherapy.
Sultan Qaboos Univ Med J
2019
,
19
, e277-283.